Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 353 of 6351
-
Chemo-Seeds planted in brain show promise against deadliest tumors
Disease control Recruiting nowPart 1 (dose escalation, safety, and preliminary efficacy) Part 1 is a non-randomised, single-arm design in 12 participants with recurrent GBM suitable for maximal safe surgical resection. Part 1 will evaluate safety, determine the MTD of irinotecan-ChemoSeed and the RP2D (corre…
Phase 2 • Sponsor: CRISM Therapeutics LTD • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a heart pill delay valve replacement?
Disease control Not yet recruitingCalcific aortic valve stenosis (CAVS) is a condition in which the aortic valve progressively narrows and stiffens due to calcium deposition, eventually impairing blood flow from the heart to the body. No drug therapy has been proven to slow CAVS progression. Individuals with mild…
Phase 2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a beetroot drink spot dangerous surgical leaks before they turn deadly?
Diagnosis Not yet recruitingThis single-center, prospective, controlled trial compares betacyanin versus conventional methods for early diagnosis and healing assessment of anastomotic leakage after rectal cancer surgery.
Sponsor: Southwest Hospital, China • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
Can a new drug improve muscle relaxation during surgery?
Disease control Not yet recruitingThe study will enroll adult patients scheduled for elective surgery requiring general anesthesia. Participants will be randomly assigned to receive either HRS-9190 for Injection or Rocuronium. The primary objective is to assess the efficacy of HRS-9190 in providing adequate neuro…
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Gut feelings: could everyday prebiotics calm anxiety and improve sleep?
Symptom relief Not yet recruitingThe goal of this study is to evaluate the effects of different products in participants experiencing feelings of anxiety. The main question it aims to answer is: \- Do these products affect feelings of anxiety and related wellness outcomes compared with a placebo? Researchers w…
Sponsor: Holobiome, Inc. • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Could a himalayan pepper sharpen your gaming edge?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if daily supplementation with a Nepalese Pepper Extract (Zanthoxylum Armatum, ZA) can improve cognitive performance and gaming performance in action video gamers aged 16 to 39, when taken over an extended period. The main questions it a…
Sponsor: Northumbria University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a Once-Daily pill tame ADHD and emotional storms?
Disease control Not yet recruitingThe primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attention-deficit/hyperactivity disorder (ADHD) and emotional dysregulation (ED).
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could Brain-Boosting exercises help older adults stay steady on their feet?
Symptom relief Not yet recruitingThis study will investigate the effects of dual-task-based high-amplitude functional exercises on balance and functional mobility in older adults with mild cognitive impairment. A total of 36 participants aged 65 years and older will be randomly assigned to either a high-amplitud…
Sponsor: Istinye University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a mind-body combo ease chronic back pain and sleeplessness?
Symptom relief Not yet recruitingThis study is a randomized controlled trial (RCT) investigating whether adding Acceptance and Commitment Therapy (ACT) to standard physiotherapy provides greater benefits for adults with chronic low back pain than physiotherapy alone. A total of 60 participants will be randomly …
Sponsor: Al-Azhar University • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can diet plus inositol or metformin tame insulin resistance in PCOS?
Disease control Not yet recruitingPolycystic ovary syndrome (PCOS) is a common endocrine disorder frequently associated with obesity, insulin resistance (IR), and metabolic dysfunction. Although lifestyle modification is recommended as first-line therapy, the optimal dietary approach for women with PCOS remains u…
Sponsor: Dicle University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Screen-Free bedtimes may amplify bedwetting medication
Disease control Recruiting nowThis randomized controlled trial will evaluate whether restricting bedtime digital-device use improves the response to desmopressin in children with primary monosymptomatic nocturnal enuresis. Participants will receive desmopressin for 8 weeks and will be assigned to either bedti…
Sponsor: Al-Azhar University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a Two-Drug combo tame high phosphorus in dialysis?
Disease control Not yet recruitingThe efficacy and safety of tenapanor plus PBs in Chinese patients are still unclear. Therefore, we aim to conduct a real-world study to explore the effect of combining two drugs with different mechanisms on hyperphosphatemia management.This real-world study will enroll hemodialys…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Wearable ECG patch could unlock hidden heart risks
Knowledge-focused By invitation onlyCor360 is an observational study evaluating whether extended wearable electrocardiogram (ECG) data can support broad-spectrum cardiac phenotyping and risk assessment beyond conventional single-purpose ambulatory rhythm monitoring. The study evaluates a clinician-facing, AI-enable…
Sponsor: Peerbridge Health, Inc • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can a new model forecast liver cancer in hepatitis b?
Knowledge-focused Not yet recruitingThe investigators propose to construct and validate an early HCC risk prediction model in a multicenter retrospective cohort of hepatitis B-related fibrosis/cirrhosis patients, using multimodal data encompassing longitudinal clinical data, serum glycomics profiles, and liver biop…
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Which Pre-Surgery combo extends life in esophageal cancer? a virtual trial seeks answers
Knowledge-focused Not yet recruitingEsophageal squamous cell carcinoma (ESCC) is highly prevalent in China, with most patients presenting with locally advanced disease. Neoadjuvant chemoradiotherapy (nCRT) is the current standard of care, while neoadjuvant immunochemotherapy (nICT) has emerged as a promising altern…
Sponsor: Henan Cancer Hospital • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can AI tailor discharge instructions to boost heart surgery recovery?
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effect of artificial intelligence-supported individualized discharge education on postoperative recovery in patients undergoing coronary artery bypass grafting. A total of 80 patients will be randomly assigned to an interventi…
Sponsor: Izmir Katip Celebi University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can a new injection quiet the painful lumps of hidradenitis suppurativa?
Disease control Recruiting nowThis is a multicenter, randomized, double-blinded, placebo-controlled clinical study of ORKA-002 in adult participants with moderate-to-severe HS.
Phase 2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can immune cells heal a rare eye ulcer?
Disease control Not yet recruitingGiven that the definitive pathogenesis of Mooren's ulcer has not been fully clarified and clinical relapse occurs frequently, natural killer (NK)-cells demonstrate unique therapeutic potential. Since NK cells do not express T-cell receptors (TCRs), they exert biological functions…
Sponsor: Suxia Li • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Sound waves to reboot the brain after stroke?
Disease control By invitation onlyThis study aims to evaluate the safety, tolerability, dose-response, and preliminary efficacy of transcranial pulse stimulation (TPS) for neurorehabilitation in patients with ischemic stroke. Participants will receive TPS at different energy levels in a dose-escalation design. Cl…
Phase 1/2 • Sponsor: Taipei Hospital, Ministry of Health and Welfare • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Surgeons test remote-controlled robotic operations for cancer patients
Disease control Not yet recruitingThis prospective, single-center pilot cohort study aims to evaluate the feasibility and safety of implementing a robotic telesurgery program in a tertiary academic referral center. Adult patients scheduled for elective robotic procedures, like radical prostatectomy or colectomy .…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC